Compound details
gamma-Crocetin
| Compound ID | CDAMM00336 |
|---|---|
| Common name | gamma-Crocetin | IUPAC name | dimethyl (2E,4E,6E,8E,10E,12E,14E)-2,6,11,15-tetramethylhexadeca-2,4,6,8,10,12,14-heptaenedioate |
| Molecular formula | C22H28O4 |
| Retention time | 24.755 |
|---|---|
| Adduct | [M+Na]+ |
| Actual mz | 379.196 | Theoretical mz | 379.188 |
| Error | 22.21 |
| Ionizaton mode | Positive |
| Instrument type | LC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60 |
| Score | 6.89 |
| Inchi key | OXNHRKGZZFWUQZ-KYBHHSLLSA-N |
|---|---|
| Smiles | O=C(OC)C(=CC=CC(=CC=CC=C(C=CC=C(C(=O)OC)C)C)C)C |
| Superclass | Lipids and lipid-like molecules |
| Class | Prenol lipids |
| Uniprot ID | Gene name | Target name | TTD_ID | Prediction source |
|---|---|---|---|---|
| P08173 | CHRM4 | Muscarinic acetylcholine receptor M4 | T20709 | SwissTargetPrediction |
| P08912 | CHRM5 | Muscarinic acetylcholine receptor M5 | T79961 | SwissTargetPrediction |
| P00533 | EGFR | Epidermal growth factor receptor erbB1 | T59328 | SwissTargetPrediction |
| P11229 | CHRM1 | Muscarinic acetylcholine receptor M1 | T28893 | SwissTargetPrediction |
| P20309 | CHRM3 | Muscarinic acetylcholine receptor M3 | T67684 | SwissTargetPrediction |
| P30542 | ADORA1 | Adenosine A1 receptor | T92072 | SwissTargetPrediction |
| P29475 | NOS1 | Nitric-oxide synthase, brain | T16117 | SwissTargetPrediction |
| P35228 | NOS2 | Nitric oxide synthase, inducible | T02703 | SwissTargetPrediction |
| P29474 | NOS3 | Nitric-oxide synthase, endothelial | T06046 | SwissTargetPrediction |
| P04818 | TYMS | Thymidylate synthase (by homology) | T98397 | SwissTargetPrediction |
| P34903 | GABRA3 | GABA A receptor alpha-3/beta-2/gamma-2 | T62292 | SwissTargetPrediction |
| P47869 | GABRA2 | GABA A receptor alpha-2/beta-2/gamma-2 | T51452 | SwissTargetPrediction |
| P41594 | GRM5 | Metabotropic glutamate receptor 5 | T99347 | SwissTargetPrediction |
| P21397 | MAOA | Monoamine oxidase A | T83875 | SwissTargetPrediction |
| P42336 | PIK3CA | PI3-kinase p110-alpha subunit | T80276 | SwissTargetPrediction |
| P43405 | SYK | Tyrosine-protein kinase SYK | T62431 | SwissTargetPrediction |
| P14416 | DRD2 | Dopamine D2 receptor | T67162 | SwissTargetPrediction |
| P21554 | CNR1 | Cannabinoid receptor 1 (by homology) | T76685 | SwissTargetPrediction |
| P34913 | EPHX2 | Epoxide hydratase | T35734 | SwissTargetPrediction |
| Q02083 | NAAA | N-acylsphingosine-amidohydrolase (by homology) | T78326 | SwissTargetPrediction |
| Q12879 | GRIN2A | Glutamate NMDA receptor; GRIN1/GRIN2A | T22285 | SwissTargetPrediction |
| P27338 | MAOB | Monoamine oxidase B | T83011 | SwissTargetPrediction |
| P28223 | HTR2A | Serotonin 2a (5-HT2a) receptor | T32060 | SwissTargetPrediction |
| P28335 | HTR2C | Serotonin 2c (5-HT2c) receptor | T83813 | SwissTargetPrediction |
| P50406 | HTR6 | Serotonin 6 (5-HT6) receptor | T16691 | SwissTargetPrediction |
| Q14416 | GRM2 | Metabotropic glutamate receptor 2 | T62820 | SwissTargetPrediction |
| P42262 | GRIA2 | Glutamate receptor ionotropic, AMPA 2 | T42392 | SwissTargetPrediction |
| P24864 | CCNE1 | Cyclin-dependent kinase 2/cyclin E1 | T10052 | SwissTargetPrediction |
| P29275 | ADORA2B | Adenosine A2b receptor | T86679 | SwissTargetPrediction |
| P43235 | CTSK | Cathepsin K | T11388 | SwissTargetPrediction |
| Q9UBN7 | HDAC6 | Histone deacetylase 6 | T22274 | SwissTargetPrediction |
| P15538 | CYP11B1 | Cytochrome P450 11B1 | T84621 | SwissTargetPrediction |
| P19099 | CYP11B2 | Cytochrome P450 11B2 | T59056 | SwissTargetPrediction |
| P07384 | CAPN1 | Calpain 1 | T92517 | SwissTargetPrediction |
| Q92769 | HDAC2 | Histone deacetylase 2 | T51191 | SwissTargetPrediction |
| P35354 | PTGS2 | Cyclooxygenase-2 | T66665 | SwissTargetPrediction |
| P45983 | MAPK8 | c-Jun N-terminal kinase 1 | T40097 | SwissTargetPrediction |
| P35968 | KDR | Vascular endothelial growth factor receptor 2 | T80975 | SwissTargetPrediction |
| O60885 | BRD4 | Bromodomain-containing protein 4 | T00407 | SwissTargetPrediction |
| Q8NER1 | TRPV1 | Vanilloid receptor | T83193 | SwissTargetPrediction |
| P04150 | NR3C1 | Glucocorticoid receptor | T40016 | SwissTargetPrediction |
| P06401 | PGR | Progesterone receptor | T22939 | SwissTargetPrediction |
| P11511 | CYP19A1 | Cytochrome P450 19A1 | T13260 | SwissTargetPrediction |
| P28845 | HSD11B1 | 11-beta-hydroxysteroid dehydrogenase 1 | T65200 | SwissTargetPrediction |
| P09917 | ALOX5 | Arachidonate 5-lipoxygenase | T00140 | SwissTargetPrediction |
| P21731 | TBXA2R | Thromboxane A2 receptor | T76198 | SwissTargetPrediction |
| P04626 | ERBB2 | Receptor protein-tyrosine kinase erbB-2 | T14597 | SwissTargetPrediction |
| Q9H2K2 | TNKS2 | Tankyrase-2 | T38087 | SwissTargetPrediction |
| O95271 | TNKS | Tankyrase-1 | T83059 | SwissTargetPrediction |
| P14061 | HSD17B1 | Estradiol 17-beta-dehydrogenase 1 | T44011 | SwissTargetPrediction |
| P06276 | BCHE | Butyrylcholinesterase | T99799 | SwissTargetPrediction |
| P55072 | VCP | Transitional endoplasmic reticulum ATPase | T12646 | SwissTargetPrediction |
| Q9Y233 | PDE10A | Phosphodiesterase 10A (by homology) | T84133 | SwissTargetPrediction |
| O75874 | IDH1 | Isocitrate dehydrogenase [NADP] cytoplasmic | T69563 | SwissTargetPrediction |
| P08172 | CHRM2 | Muscarinic acetylcholine receptor M2 | T46185 | SwissTargetPrediction |
| P30559 | OXTR | Oxytocin receptor (by homology) | T84486 | SwissTargetPrediction |
| P37288 | AVPR1A | Vasopressin V1a receptor (by homology) | T79232 | SwissTargetPrediction |
| P30518 | AVPR2 | Vasopressin V2 receptor (by homology) | T66237 | SwissTargetPrediction |
| P07711 | CTSL | Cathepsin L | T98691 | SwissTargetPrediction |
| P07858 | CTSB | Cathepsin (B and K) | T61746 | SwissTargetPrediction |
| P62942 | FKBP1A | FK506-binding protein 1A | T76059 | SwissTargetPrediction |
| P49356 | FNTB | Farnesyl protein transferase | T13127 | SwissTargetPrediction |
| P49810 | PSEN2 | Gamma-secretase | T99204 | SwissTargetPrediction |
| Q02750 | MAP2K1 | Dual specificity mitogen-activated protein kinase kinase 1 | T99057 | SwissTargetPrediction |
| P08581 | MET | Hepatocyte growth factor receptor | T40474 | SwissTargetPrediction |
| P17948 | FLT1 | Vascular endothelial growth factor receptor 1 | T63966 | SwissTargetPrediction |
| P10721 | KIT | Stem cell growth factor receptor | T57700 | SwissTargetPrediction |
| Q15078 | CDK5R1 | Cyclin-dependent kinase 5/CDK5 activator 1 | T09513 | SwissTargetPrediction |
| P40763 | STAT3 | Signal transducer and activator of transcription 3 | T29130 | SwissTargetPrediction |
| P25774 | CTSS | Cathepsin S | T68290 | SwissTargetPrediction |
| P48039 | MTNR1A | Melatonin receptor 1A | T97613 | SwissTargetPrediction |
| P49286 | MTNR1B | Melatonin receptor 1B | T48268 | SwissTargetPrediction |
| P34972 | CNR2 | Cannabinoid receptor 2 | T37693 | SwissTargetPrediction |
| Q9HAZ1 | CLK4 | Dual specificity protein kinase CLK4 | T98225 | SwissTargetPrediction |
| P09619 | PDGFRB | Platelet-derived growth factor receptor beta | T59102 | SwissTargetPrediction |
| P34998 | CRHR1 | Corticotropin releasing factor receptor 1 (by homology) | T45262 | SwissTargetPrediction |
| O00763 | ACACB | Acetyl-CoA carboxylase 2 | T08922 | SwissTargetPrediction |
| P24557 | TBXAS1 | Thromboxane-A synthase | T78356 | SwissTargetPrediction |
| P00749 | PLAU | Urokinase-type plasminogen activator | T17758 | SwissTargetPrediction |
| Q16602 | CALCRL | Calcitonin gene-related peptide type 1 receptor | T02226 | SwissTargetPrediction |
| Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | T23787 | SwissTargetPrediction |
| P30536 | TSPO | Translocator protein (by homology) | T75440 | SwissTargetPrediction |
| O43614 | HCRTR2 | Orexin receptor 2 | T69485 | SwissTargetPrediction |
| O43613 | HCRTR1 | Orexin receptor 1 | T73482 | SwissTargetPrediction |
| O14649 | KCNK3 | Potassium channel subfamily K member 3 | T15795 | SwissTargetPrediction |
| Q9NPC2 | KCNK9 | Potassium channel subfamily K member 9 | T57613 | SwissTargetPrediction |
| P53671 | LIMK2 | LIM domain kinase 2 | T09133 | SwissTargetPrediction |
| P25116 | F2R | Proteinase-activated receptor 1 | T36483 | SwissTargetPrediction |
| P53609 | PGGT1B | Geranylgeranyl transferase type I | T76396 | SwissTargetPrediction |
| P05129 | PRKCG | Protein kinase C gamma | T47107 | SwissTargetPrediction |
| P18507 | GABRG2 | GABA-A receptor; alpha-6/beta-3/gamma-2 | T08910 | SwissTargetPrediction |
| Q96RI0 | F2RL3 | Proteinase activated receptor 4 | T30414 | SwissTargetPrediction |
| P19634 | SLC9A1 | Sodium/hydrogen exchanger 1 | T82028 | SwissTargetPrediction |
| O43194 | GPR39 | G-protein coupled receptor 39 | T88531 | SwissTargetPrediction |
| TTD_ID | Disease_ID | Disease name | ICD_11 | Uniprot ID | Gene names |
|---|---|---|---|---|---|
| T20709 | DI0037 | Asthma | [ICD-11: CA23] | P08173 | CHRM4 |
| T20709 | DI0141 | Eye anterior segment structural developmental anomaly | [ICD-11: LA11] | P08173 | CHRM4 |
| T20709 | DI0166 | Glaucoma | [ICD-11: 9C61] | P08173 | CHRM4 |
| T20709 | DI0293 | Nausea/vomiting | [ICD-11: MD90] | P08173 | CHRM4 |
| T20709 | DI0362 | Respiratory system disease | [ICD-11: CB40-CB7Z] | P08173 | CHRM4 |
| T79961 | DI0002 | Abnormal micturition | [ICD-11: MF50] | P08912 | CHRM5 |
| T79961 | DI0032 | Anterior uveitis | [ICD-11: 9A96] | P08912 | CHRM5 |
| T79961 | DI0034 | Appearance/behaviour symptom | [ICD-11: MB23] | P08912 | CHRM5 |
| T79961 | DI0037 | Asthma | [ICD-11: CA23] | P08912 | CHRM5 |
| T79961 | DI0061 | Brain disease | [ICD-11: 8C70-8E61] | P08912 | CHRM5 |
| T79961 | DI0071 | Central and peripheral nervous disease | [ICD-11: 8A04-8E7Z] | P08912 | CHRM5 |
| T79961 | DI0086 | Chronic obstructive pulmonary disease | [ICD-11: CA22] | P08912 | CHRM5 |
| T79961 | DI0093 | Cognition symptoms/signs/clinical symptom | [ICD-11: MB21] | P08912 | CHRM5 |
| T79961 | DI0105 | Cough | [ICD-11: MD12] | P08912 | CHRM5 |
| T79961 | DI0124 | Digestive system disease | [ICD-11: DE2Z] | P08912 | CHRM5 |
| T79961 | DI0145 | Female pelvic pain | [ICD-11: GA34] | P08912 | CHRM5 |
| T79961 | DI0154 | Functional bladder disorder | [ICD-11: GC50] | P08912 | CHRM5 |
| T79961 | DI0158 | Gastritis | [ICD-11: DA42] | P08912 | CHRM5 |
| T79961 | DI0162 | General examination | [ICD-11: QA00] | P08912 | CHRM5 |
| T79961 | DI0166 | Glaucoma | [ICD-11: 9C61] | P08912 | CHRM5 |
| T79961 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P08912 | CHRM5 |
| T79961 | DI0208 | Infectious gastroenteritis/colitis | [ICD-11: 1A40] | P08912 | CHRM5 |
| T79961 | DI0218 | Irritable bowel syndrome | [ICD-11: DD91] | P08912 | CHRM5 |
| T79961 | DI0307 | Nystagmus | [ICD-11: 9C84] | P08912 | CHRM5 |
| T79961 | DI0315 | Oesophagus motility disorder | [ICD-11: DA21] | P08912 | CHRM5 |
| T79961 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P08912 | CHRM5 |
| T79961 | DI0329 | Pancreatitis | [ICD-11: DC31-DC34] | P08912 | CHRM5 |
| T79961 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P08912 | CHRM5 |
| T79961 | DI0333 | Peptic ulcer | [ICD-11: DA61] | P08912 | CHRM5 |
| T79961 | DI0338 | Polyuria | [ICD-11: MF55] | P08912 | CHRM5 |
| T79961 | DI0411 | Tonus and reflex abnormality | [ICD-11: MB47] | P08912 | CHRM5 |
| T79961 | DI0421 | Unspecific substance harmful effect | [ICD-11: NE6Z] | P08912 | CHRM5 |
| T79961 | DI0424 | Urgency | [ICD-11: N.A.] | P08912 | CHRM5 |
| T59328 | DI0030 | Angina pectoris | [ICD-11: BA40] | P00533 | EGFR |
| T59328 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P00533 | EGFR |
| T59328 | DI0095 | Colorectal cancer | [ICD-11: 2B91] | P00533 | EGFR |
| T59328 | DI0121 | Diabetic foot ulcer | [ICD-11: BD54] | P00533 | EGFR |
| T59328 | DI0220 | Ischemia | [ICD-11: 8B10-8B11] | P00533 | EGFR |
| T59328 | DI0238 | Lung cancer | [ICD-11: 2C25] | P00533 | EGFR |
| T59328 | DI0303 | Non-small-cell lung cancer | [ICD-11: 2C25] | P00533 | EGFR |
| T59328 | DI0361 | Renal cell carcinoma | [ICD-11: 2C90] | P00533 | EGFR |
| T59328 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P00533 | EGFR |
| T59328 | DI0420 | Unspecific body region injury | [ICD-11: ND56] | P00533 | EGFR |
| T28893 | DI0001 | Abdominal pelvic pain | [ICD-11: MD81] | P11229 | CHRM1 |
| T28893 | DI0086 | Chronic obstructive pulmonary disease | [ICD-11: CA22] | P11229 | CHRM1 |
| T28893 | DI0101 | Corneal disease | [ICD-11: 9A76-9A78] | P11229 | CHRM1 |
| T28893 | DI0129 | Dystonic disorder | [ICD-11: 8A02] | P11229 | CHRM1 |
| T28893 | DI0154 | Functional bladder disorder | [ICD-11: GC50] | P11229 | CHRM1 |
| T28893 | DI0157 | Gastric ulcer | [ICD-11: DA60] | P11229 | CHRM1 |
| T28893 | DI0166 | Glaucoma | [ICD-11: 9C61] | P11229 | CHRM1 |
| T28893 | DI0186 | Hyperhidrosis | [ICD-11: EE00] | P11229 | CHRM1 |
| T28893 | DI0218 | Irritable bowel syndrome | [ICD-11: DD91] | P11229 | CHRM1 |
| T28893 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P11229 | CHRM1 |
| T28893 | DI0333 | Peptic ulcer | [ICD-11: DA61] | P11229 | CHRM1 |
| T28893 | DI0371 | Sebaceous gland disorder | [ICD-11: ED91] | P11229 | CHRM1 |
| T67684 | DI0037 | Asthma | [ICD-11: CA23] | P20309 | CHRM3 |
| T67684 | DI0086 | Chronic obstructive pulmonary disease | [ICD-11: CA22] | P20309 | CHRM3 |
| T67684 | DI0154 | Functional bladder disorder | [ICD-11: GC50] | P20309 | CHRM3 |
| T67684 | DI0166 | Glaucoma | [ICD-11: 9C61] | P20309 | CHRM3 |
| T67684 | DI0293 | Nausea/vomiting | [ICD-11: MD90] | P20309 | CHRM3 |
| T67684 | DI0333 | Peptic ulcer | [ICD-11: DA61] | P20309 | CHRM3 |
| T67684 | DI0362 | Respiratory system disease | [ICD-11: CB40-CB7Z] | P20309 | CHRM3 |
| T67684 | DI0371 | Sebaceous gland disorder | [ICD-11: ED91] | P20309 | CHRM3 |
| T67684 | DI0382 | Sjogren syndrome | [ICD-11: 4A43] | P20309 | CHRM3 |
| T67684 | DI0411 | Tonus and reflex abnormality | [ICD-11: MB47] | P20309 | CHRM3 |
| T92072 | DI0319 | Orthostatic hypotension | [ICD-11: BA21] | P30542 | ADORA1 |
| T16117 | DI0173 | Headache | [ICD-11: 8A80-8A84] | P29475 | NOS1 |
| T16117 | DI0264 | Migraine | [ICD-11: 8A80] | P29475 | NOS1 |
| T02703 | DI0083 | Chronic kidney disease | [ICD-11: GB61] | P35228 | NOS2 |
| T02703 | DI0320 | Osteoarthritis | [ICD-11: FA00-FA05] | P35228 | NOS2 |
| T02703 | DI0375 | Sepsis | [ICD-11: 1G40-1G41] | P35228 | NOS2 |
| T02703 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P35228 | NOS2 |
| T06046 | DI0287 | Myocardial infarction | [ICD-11: BA41-BA43] | P29474 | NOS3 |
| T98397 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P04818 | TYMS |
| T98397 | DI0395 | Stomach cancer | [ICD-11: 2B72] | P04818 | TYMS |
| T62292 | DI0216 | Intentional self-harm | [ICD-11: PC91] | P34903 | GABRA3 |
| T51452 | DI0216 | Intentional self-harm | [ICD-11: PC91] | P47869 | GABRA2 |
| T99347 | DI0152 | Fragile X chromosome | [ICD-11: LD55] | P41594 | GRM5 |
| T99347 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P41594 | GRM5 |
| T83875 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P21397 | MAOA |
| T83875 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P21397 | MAOA |
| T80276 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P42336 | PIK3CA |
| T80276 | DI0151 | Follicular lymphoma | [ICD-11: 2A80] | P42336 | PIK3CA |
| T80276 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | P42336 | PIK3CA |
| T62431 | DI0403 | Thrombocytopenia | [ICD-11: 3B64] | P43405 | SYK |
| T67162 | DI0022 | Allergic/hypersensitivity disorder | [ICD-11: 4A80-4A8Z] | P14416 | DRD2 |
| T67162 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | P14416 | DRD2 |
| T67162 | DI0037 | Asthma | [ICD-11: CA23] | P14416 | DRD2 |
| T67162 | DI0040 | Attention deficit hyperactivity disorder | [ICD-11: 6A05] | P14416 | DRD2 |
| T67162 | DI0051 | Bipolar disorder | [ICD-11: 6A60] | P14416 | DRD2 |
| T67162 | DI0063 | Breathing abnormality | [ICD-11: MD11] | P14416 | DRD2 |
| T67162 | DI0070 | Cardiovascular disease | [ICD-11: BA00-BE2Z] | P14416 | DRD2 |
| T67162 | DI0073 | Cerebral ischaemia | [ICD-11: 8B1Z] | P14416 | DRD2 |
| T67162 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P14416 | DRD2 |
| T67162 | DI0124 | Digestive system disease | [ICD-11: DE2Z] | P14416 | DRD2 |
| T67162 | DI0137 | Essential hypertension | [ICD-11: BA00] | P14416 | DRD2 |
| T67162 | DI0142 | Faecal incontinence | [ICD-11: ME07] | P14416 | DRD2 |
| T67162 | DI0156 | Gangrene | [ICD-11: MC85] | P14416 | DRD2 |
| T67162 | DI0166 | Glaucoma | [ICD-11: 9C61] | P14416 | DRD2 |
| T67162 | DI0175 | Heart failure | [ICD-11: BD10-BD1Z] | P14416 | DRD2 |
| T67162 | DI0185 | Hyperaemia | [ICD-11: 9A61-9B7Y] | P14416 | DRD2 |
| T67162 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P14416 | DRD2 |
| T67162 | DI0196 | Hypotension | [ICD-11: BA20-BA21] | P14416 | DRD2 |
| T67162 | DI0205 | Inborn porphyrin/heme metabolism error | [ICD-11: 5C58] | P14416 | DRD2 |
| T67162 | DI0214 | Insomnia | [ICD-11: 7A00-7A0Z] | P14416 | DRD2 |
| T67162 | DI0222 | Itching | [ICD-11: 1F28-1G07] | P14416 | DRD2 |
| T67162 | DI0264 | Migraine | [ICD-11: 8A80] | P14416 | DRD2 |
| T67162 | DI0293 | Nausea/vomiting | [ICD-11: MD90] | P14416 | DRD2 |
| T67162 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P14416 | DRD2 |
| T67162 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P14416 | DRD2 |
| T67162 | DI0337 | Pituitary gland disorder | [ICD-11: 5A60-5A61] | P14416 | DRD2 |
| T67162 | DI0340 | Postpartum haemorrhage | [ICD-11: JA43] | P14416 | DRD2 |
| T67162 | DI0354 | Psychotic disorder | [ICD-11: 6A20-6A25] | P14416 | DRD2 |
| T67162 | DI0356 | Pulmonary hypertension | [ICD-11: BB01] | P14416 | DRD2 |
| T67162 | DI0370 | Schizophrenia | [ICD-11: 6A20] | P14416 | DRD2 |
| T67162 | DI0396 | Substance abuse | [ICD-11: 6C40] | P14416 | DRD2 |
| T67162 | DI0408 | Thyrotoxicosis | [ICD-11: 5A02] | P14416 | DRD2 |
| T67162 | DI0417 | Type 2 diabetes mellitus | [ICD-11: 5A11] | P14416 | DRD2 |
| T76685 | DI0031 | Anorexia nervosa | [ICD-11: 6B80] | P21554 | CNR1 |
| T76685 | DI0214 | Insomnia | [ICD-11: 7A00-7A0Z] | P21554 | CNR1 |
| T76685 | DI0308 | Obesity | [ICD-11: 5B80-5B81] | P21554 | CNR1 |
| T35734 | DI0086 | Chronic obstructive pulmonary disease | [ICD-11: CA22] | P34913 | EPHX2 |
| T35734 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P34913 | EPHX2 |
| T22285 | DI0306 | Nutritional deficiency | [ICD-11: 5B50-5B71] | Q12879 | GRIN2A |
| T83011 | DI0115 | Dementia | [ICD-11: 6D80-6D8Z] | P27338 | MAOB |
| T83011 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P27338 | MAOB |
| T83011 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P27338 | MAOB |
| T83011 | DI0243 | Malaria | [ICD-11: 1F40-1F45] | P27338 | MAOB |
| T83011 | DI0264 | Migraine | [ICD-11: 8A80] | P27338 | MAOB |
| T83011 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P27338 | MAOB |
| T32060 | DI0009 | Acute diabete complication | [ICD-11: 5A2Y] | P28223 | HTR2A |
| T32060 | DI0033 | Anxiety disorder | [ICD-11: 6B00-6B0Z] | P28223 | HTR2A |
| T32060 | DI0073 | Cerebral ischaemia | [ICD-11: 8B1Z] | P28223 | HTR2A |
| T32060 | DI0270 | Mood disorder | [ICD-11: 6A60-6E23] | P28223 | HTR2A |
| T32060 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P28223 | HTR2A |
| T32060 | DI0337 | Pituitary gland disorder | [ICD-11: 5A60-5A61] | P28223 | HTR2A |
| T32060 | DI0370 | Schizophrenia | [ICD-11: 6A20] | P28223 | HTR2A |
| T83813 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P28335 | HTR2C |
| T83813 | DI0264 | Migraine | [ICD-11: 8A80] | P28335 | HTR2C |
| T83813 | DI0308 | Obesity | [ICD-11: 5B80-5B81] | P28335 | HTR2C |
| T83813 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P28335 | HTR2C |
| T83813 | DI0337 | Pituitary gland disorder | [ICD-11: 5A60-5A61] | P28335 | HTR2C |
| T16691 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | P50406 | HTR6 |
| T16691 | DI0370 | Schizophrenia | [ICD-11: 6A20] | P50406 | HTR6 |
| T62820 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | Q14416 | GRM2 |
| T62820 | DI0051 | Bipolar disorder | [ICD-11: 6A60] | Q14416 | GRM2 |
| T62820 | DI0116 | Dengue fever | [ICD-11: 1D2Z] | Q14416 | GRM2 |
| T62820 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | Q14416 | GRM2 |
| T62820 | DI0134 | Epilepsy/seizure | [ICD-11: 8A61-8A6Z] | Q14416 | GRM2 |
| T62820 | DI0256 | Mental/behavioural/neurodevelopmental disorder | [ICD-11: 6E20-6E8Z] | Q14416 | GRM2 |
| T62820 | DI0308 | Obesity | [ICD-11: 5B80-5B81] | Q14416 | GRM2 |
| T62820 | DI0354 | Psychotic disorder | [ICD-11: 6A20-6A25] | Q14416 | GRM2 |
| T62820 | DI0370 | Schizophrenia | [ICD-11: 6A20] | Q14416 | GRM2 |
| T42392 | DI0298 | Neuropathy | [ICD-11: 8C0Z] | P42262 | GRIA2 |
| T86679 | DI0180 | Herpes simplex infection | [ICD-11: 1F00] | P29275 | ADORA2B |
| T86679 | DI0397 | Supraventricular tachyarrhythmia | [ICD-11: BC81] | P29275 | ADORA2B |
| T11388 | DI0237 | Low bone mass disorder | [ICD-11: FB83] | P43235 | CTSK |
| T22274 | DI0274 | Multiple myeloma | [ICD-11: 2A83] | Q9UBN7 | HDAC6 |
| T22274 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q9UBN7 | HDAC6 |
| T84621 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P15538 | CYP11B1 |
| T84621 | DI0108 | Cushing syndrome | [ICD-11: 5A70] | P15538 | CYP11B1 |
| T59056 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P19099 | CYP11B2 |
| T51191 | DI0241 | Lymphoma | [ICD-11: 2A80-2A86] | Q92769 | HDAC2 |
| T51191 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q92769 | HDAC2 |
| T66665 | DI0087 | Chronic pain | [ICD-11: MG30] | P35354 | PTGS2 |
| T66665 | DI0145 | Female pelvic pain | [ICD-11: GA34] | P35354 | PTGS2 |
| T66665 | DI0188 | Hyper-lipoproteinaemia | [ICD-11: 5C80] | P35354 | PTGS2 |
| T66665 | DI0207 | Indeterminate colitis | [ICD-11: DD72] | P35354 | PTGS2 |
| T66665 | DI0227 | Knee osteoarthritis | [ICD-11: FA01] | P35354 | PTGS2 |
| T66665 | DI0320 | Osteoarthritis | [ICD-11: FA00-FA05] | P35354 | PTGS2 |
| T66665 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P35354 | PTGS2 |
| T66665 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P35354 | PTGS2 |
| T66665 | DI0416 | Tuberculosis | [ICD-11: 1B10-1B12] | P35354 | PTGS2 |
| T40097 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P45983 | MAPK8 |
| T80975 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P35968 | KDR |
| T80975 | DI0095 | Colorectal cancer | [ICD-11: 2B91] | P35968 | KDR |
| T80975 | DI0160 | Gastrointestinal stromal tumour | [ICD-11: 2B5B] | P35968 | KDR |
| T80975 | DI0244 | Malignant digestive organ neoplasm | [ICD-11: 2C11] | P35968 | KDR |
| T80975 | DI0361 | Renal cell carcinoma | [ICD-11: 2C90] | P35968 | KDR |
| T80975 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P35968 | KDR |
| T80975 | DI0395 | Stomach cancer | [ICD-11: 2B72] | P35968 | KDR |
| T80975 | DI0403 | Thrombocytopenia | [ICD-11: 3B64] | P35968 | KDR |
| T80975 | DI0407 | Thyroid cancer | [ICD-11: 2D10] | P35968 | KDR |
| T83193 | DI0163 | General pain disorder | [ICD-11: 8E43] | Q8NER1 | TRPV1 |
| T40016 | DI0016 | Adaptive immunity immunodeficiency | [ICD-11: 4A01] | P04150 | NR3C1 |
| T40016 | DI0022 | Allergic/hypersensitivity disorder | [ICD-11: 4A80-4A8Z] | P04150 | NR3C1 |
| T40016 | DI0037 | Asthma | [ICD-11: CA23] | P04150 | NR3C1 |
| T40016 | DI0086 | Chronic obstructive pulmonary disease | [ICD-11: CA22] | P04150 | NR3C1 |
| T40016 | DI0108 | Cushing syndrome | [ICD-11: 5A70] | P04150 | NR3C1 |
| T40016 | DI0280 | Muscular dystrophy | [ICD-11: 8C70] | P04150 | NR3C1 |
| T40016 | DI0314 | Oesophagitis | [ICD-11: DA24] | P04150 | NR3C1 |
| T40016 | DI0339 | Postoperative inflammation | [ICD-11: 1A00-CA43] | P04150 | NR3C1 |
| T40016 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P04150 | NR3C1 |
| T40016 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P04150 | NR3C1 |
| T40016 | DI0432 | Vasomotor/allergic rhinitis | [ICD-11: CA08] | P04150 | NR3C1 |
| T22939 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P06401 | PGR |
| T22939 | DI0100 | Contraceptive management | [ICD-11: QA21] | P06401 | PGR |
| T22939 | DI0255 | Menstrual cycle bleeding disorder | [ICD-11: GA20] | P06401 | PGR |
| T22939 | DI0344 | Preterm labour/delivery | [ICD-11: JB00] | P06401 | PGR |
| T22939 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P06401 | PGR |
| T13260 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P11511 | CYP19A1 |
| T13260 | DI0108 | Cushing syndrome | [ICD-11: 5A70] | P11511 | CYP19A1 |
| T65200 | DI0210 | Influenza | [ICD-11: 1E30-1E32] | P28845 | HSD11B1 |
| T65200 | DI0239 | Lupus erythematosus | [ICD-11: 4A40] | P28845 | HSD11B1 |
| T65200 | DI0417 | Type 2 diabetes mellitus | [ICD-11: 5A11] | P28845 | HSD11B1 |
| T00140 | DI0037 | Asthma | [ICD-11: CA23] | P09917 | ALOX5 |
| T00140 | DI0147 | Filariasis | [ICD-11: 1F66] | P09917 | ALOX5 |
| T00140 | DI0403 | Thrombocytopenia | [ICD-11: 3B64] | P09917 | ALOX5 |
| T76198 | DI0102 | Coronary atherosclerosis | [ICD-11: BA52] | P21731 | TBXA2R |
| T76198 | DI0121 | Diabetic foot ulcer | [ICD-11: BD54] | P21731 | TBXA2R |
| T76198 | DI0287 | Myocardial infarction | [ICD-11: BA41-BA43] | P21731 | TBXA2R |
| T76198 | DI0378 | Sexual dysfunction | [ICD-11: HA00-HA01] | P21731 | TBXA2R |
| T14597 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P04626 | ERBB2 |
| T14597 | DI0238 | Lung cancer | [ICD-11: 2C25] | P04626 | ERBB2 |
| T14597 | DI0346 | Prostate cancer | [ICD-11: 2C82] | P04626 | ERBB2 |
| T38087 | DI0321 | Ovarian cancer | [ICD-11: 2C73] | Q9H2K2 | TNKS2 |
| T83059 | DI0060 | Brain cancer | [ICD-11: 2A00] | O95271 | TNKS |
| T83059 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | O95271 | TNKS |
| T83059 | DI0321 | Ovarian cancer | [ICD-11: 2C73] | O95271 | TNKS |
| T83059 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | O95271 | TNKS |
| T99799 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P06276 | BCHE |
| T99799 | DI0411 | Tonus and reflex abnormality | [ICD-11: MB47] | P06276 | BCHE |
| T12646 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | P55072 | VCP |
| T12646 | DI0274 | Multiple myeloma | [ICD-11: 2A83] | P55072 | VCP |
| T12646 | DI0284 | Myelodysplastic syndrome | [ICD-11: 2A37] | P55072 | VCP |
| T12646 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P55072 | VCP |
| T84133 | DI0079 | Choreiform disorder | [ICD-11: 8A01] | Q9Y233 | PDE10A |
| T84133 | DI0206 | Inborn purine/pyrimidine/nucleotide metabolism error | [ICD-11: 5C55] | Q9Y233 | PDE10A |
| T84133 | DI0218 | Irritable bowel syndrome | [ICD-11: DD91] | Q9Y233 | PDE10A |
| T84133 | DI0370 | Schizophrenia | [ICD-11: 6A20] | Q9Y233 | PDE10A |
| T84133 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q9Y233 | PDE10A |
| T69563 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | O75874 | IDH1 |
| T46185 | DI0037 | Asthma | [ICD-11: CA23] | P08172 | CHRM2 |
| T46185 | DI0166 | Glaucoma | [ICD-11: 9C61] | P08172 | CHRM2 |
| T46185 | DI0278 | Muscle disorder | [ICD-11: FB32-FB3Z] | P08172 | CHRM2 |
| T46185 | DI0333 | Peptic ulcer | [ICD-11: DA61] | P08172 | CHRM2 |
| T46185 | DI0362 | Respiratory system disease | [ICD-11: CB40-CB7Z] | P08172 | CHRM2 |
| T46185 | DI0371 | Sebaceous gland disorder | [ICD-11: ED91] | P08172 | CHRM2 |
| T84486 | DI0009 | Acute diabete complication | [ICD-11: 5A2Y] | P30559 | OXTR |
| T84486 | DI0041 | Autism spectrum disorder | [ICD-11: 6A02] | P30559 | OXTR |
| T84486 | DI0340 | Postpartum haemorrhage | [ICD-11: JA43] | P30559 | OXTR |
| T79232 | DI0009 | Acute diabete complication | [ICD-11: 5A2Y] | P37288 | AVPR1A |
| T79232 | DI0041 | Autism spectrum disorder | [ICD-11: 6A02] | P37288 | AVPR1A |
| T79232 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P37288 | AVPR1A |
| T79232 | DI0194 | Hypo-osmolality/hyponatraemia | [ICD-11: 5C72] | P37288 | AVPR1A |
| T79232 | DI0236 | Localisation | [ICD-11: N.A.] | P37288 | AVPR1A |
| T66237 | DI0009 | Acute diabete complication | [ICD-11: 5A2Y] | P30518 | AVPR2 |
| T66237 | DI0041 | Autism spectrum disorder | [ICD-11: 6A02] | P30518 | AVPR2 |
| T66237 | DI0131 | Enuresis | [ICD-11: 6C00] | P30518 | AVPR2 |
| T66237 | DI0194 | Hypo-osmolality/hyponatraemia | [ICD-11: 5C72] | P30518 | AVPR2 |
| T66237 | DI0337 | Pituitary gland disorder | [ICD-11: 5A60-5A61] | P30518 | AVPR2 |
| T66237 | DI0338 | Polyuria | [ICD-11: MF55] | P30518 | AVPR2 |
| T98691 | DI0263 | Middle East Respiratory Syndrome | [ICD-11: 1D64] | P07711 | CTSL |
| T98691 | DI0376 | Severe acute respiratory syndrome | [ICD-11: 1D65] | P07711 | CTSL |
| T61746 | DI0023 | Alopecia | [ICD-11: ED70] | P07858 | CTSB |
| T61746 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | P07858 | CTSB |
| T61746 | DI0037 | Asthma | [ICD-11: CA23] | P07858 | CTSB |
| T61746 | DI0055 | Bone cancer | [ICD-11: 2B5Z] | P07858 | CTSB |
| T61746 | DI0060 | Brain cancer | [ICD-11: 2A00] | P07858 | CTSB |
| T61746 | DI0067 | Cardiac arrest | [ICD-11: MC82] | P07858 | CTSB |
| T61746 | DI0074 | Cerebral ischaemic stroke | [ICD-11: 8B11] | P07858 | CTSB |
| T61746 | DI0086 | Chronic obstructive pulmonary disease | [ICD-11: CA22] | P07858 | CTSB |
| T61746 | DI0087 | Chronic pain | [ICD-11: MG30] | P07858 | CTSB |
| T61746 | DI0110 | Cystic fibrosis | [ICD-11: CA25] | P07858 | CTSB |
| T61746 | DI0124 | Digestive system disease | [ICD-11: DE2Z] | P07858 | CTSB |
| T61746 | DI0178 | Hepatic fibrosis/cirrhosis | [ICD-11: DB93] | P07858 | CTSB |
| T61746 | DI0199 | Idiopathic interstitial pneumonitis | [ICD-11: CB03] | P07858 | CTSB |
| T61746 | DI0253 | Meningioma | [ICD-11: 2A01] | P07858 | CTSB |
| T61746 | DI0262 | Metastatic tumour | [ICD-11: 2D50-2E2Z] | P07858 | CTSB |
| T61746 | DI0275 | Multiple sclerosis | [ICD-11: 8A40] | P07858 | CTSB |
| T61746 | DI0296 | Neurodegenerative disorder | [ICD-11: 8A20-8A23] | P07858 | CTSB |
| T61746 | DI0320 | Osteoarthritis | [ICD-11: FA00-FA05] | P07858 | CTSB |
| T61746 | DI0351 | Psoriasis | [ICD-11: EA90] | P07858 | CTSB |
| T61746 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P07858 | CTSB |
| T76059 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P62942 | FKBP1A |
| T76059 | DI0349 | Pruritus | [ICD-11: EC90] | P62942 | FKBP1A |
| T76059 | DI0413 | Transplant rejection | [ICD-11: NE84] | P62942 | FKBP1A |
| T13127 | DI0342 | Premature ageing appearance | [ICD-11: LD2B] | P49356 | FNTB |
| T99204 | DI0320 | Osteoarthritis | [ICD-11: FA00-FA05] | P49810 | PSEN2 |
| T99204 | DI0380 | Shoulder lesion | [ICD-11: FB53] | P49810 | PSEN2 |
| T99204 | DI0390 | Soft tissue disorder | [ICD-11: FB56] | P49810 | PSEN2 |
| T99057 | DI0262 | Metastatic tumour | [ICD-11: 2D50-2E2Z] | Q02750 | MAP2K1 |
| T99057 | DI0336 | Phakomatoses/hamartoneoplastic syndrome | [ICD-11: LD2D] | Q02750 | MAP2K1 |
| T40474 | DI0238 | Lung cancer | [ICD-11: 2C25] | P08581 | MET |
| T40474 | DI0303 | Non-small-cell lung cancer | [ICD-11: 2C25] | P08581 | MET |
| T40474 | DI0407 | Thyroid cancer | [ICD-11: 2D10] | P08581 | MET |
| T63966 | DI0361 | Renal cell carcinoma | [ICD-11: 2C90] | P17948 | FLT1 |
| T57700 | DI0058 | Bone/articular cartilage neoplasm | [ICD-11: 2F7B] | P10721 | KIT |
| T57700 | DI0095 | Colorectal cancer | [ICD-11: 2B91] | P10721 | KIT |
| T57700 | DI0160 | Gastrointestinal stromal tumour | [ICD-11: 2B5B] | P10721 | KIT |
| T57700 | DI0250 | Mature B-cell lymphoma | [ICD-11: 2A85] | P10721 | KIT |
| T57700 | DI0286 | Myeloproliferative neoplasm | [ICD-11: 2A20] | P10721 | KIT |
| T57700 | DI0361 | Renal cell carcinoma | [ICD-11: 2C90] | P10721 | KIT |
| T57700 | DI0403 | Thrombocytopenia | [ICD-11: 3B64] | P10721 | KIT |
| T29130 | DI0351 | Psoriasis | [ICD-11: EA90] | P40763 | STAT3 |
| T68290 | DI0042 | Autoimmune disease | [ICD-11: 4A40-4A45] | P25774 | CTSS |
| T68290 | DI0092 | Coeliac disease | [ICD-11: DA95] | P25774 | CTSS |
| T68290 | DI0107 | Crohn disease | [ICD-11: DD70] | P25774 | CTSS |
| T68290 | DI0120 | Diabetes mellitus | [ICD-11: 5A10] | P25774 | CTSS |
| T68290 | DI0163 | General pain disorder | [ICD-11: 8E43] | P25774 | CTSS |
| T68290 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P25774 | CTSS |
| T68290 | DI0382 | Sjogren syndrome | [ICD-11: 4A43] | P25774 | CTSS |
| T97613 | DI0214 | Insomnia | [ICD-11: 7A00-7A0Z] | P48039 | MTNR1A |
| T48268 | DI0214 | Insomnia | [ICD-11: 7A00-7A0Z] | P49286 | MTNR1B |
| T37693 | DI0040 | Attention deficit hyperactivity disorder | [ICD-11: 6A05] | P34972 | CNR2 |
| T37693 | DI0214 | Insomnia | [ICD-11: 7A00-7A0Z] | P34972 | CNR2 |
| T59102 | DI0009 | Acute diabete complication | [ICD-11: 5A2Y] | P09619 | PDGFRB |
| T59102 | DI0361 | Renal cell carcinoma | [ICD-11: 2C90] | P09619 | PDGFRB |
| T59102 | DI0403 | Thrombocytopenia | [ICD-11: 3B64] | P09619 | PDGFRB |
| T45262 | DI0394 | Staphylococcal/streptococcal disease | [ICD-11: 1B5Y] | P34998 | CRHR1 |
| T08922 | DI0417 | Type 2 diabetes mellitus | [ICD-11: 5A11] | O00763 | ACACB |
| T78356 | DI0030 | Angina pectoris | [ICD-11: BA40] | P24557 | TBXAS1 |
| T17758 | DI0211 | Inherited coagulation factor deficiency | [ICD-11: 3B14] | P00749 | PLAU |
| T17758 | DI0287 | Myocardial infarction | [ICD-11: BA41-BA43] | P00749 | PLAU |
| T23787 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q16875 | PFKFB3 |
| T75440 | DI0033 | Anxiety disorder | [ICD-11: 6B00-6B0Z] | P30536 | TSPO |
| T75440 | DI0134 | Epilepsy/seizure | [ICD-11: 8A61-8A6Z] | P30536 | TSPO |
| T75440 | DI0214 | Insomnia | [ICD-11: 7A00-7A0Z] | P30536 | TSPO |
| T75440 | DI0216 | Intentional self-harm | [ICD-11: PC91] | P30536 | TSPO |
| T75440 | DI0271 | Mood/affect symptom | [ICD-11: MB24] | P30536 | TSPO |
| T75440 | DI0411 | Tonus and reflex abnormality | [ICD-11: MB47] | P30536 | TSPO |
| T69485 | DI0214 | Insomnia | [ICD-11: 7A00-7A0Z] | O43614 | HCRTR2 |
| T73482 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | O43613 | HCRTR1 |
| T73482 | DI0214 | Insomnia | [ICD-11: 7A00-7A0Z] | O43613 | HCRTR1 |
| T73482 | DI0317 | Opioid use disorder | [ICD-11: 6C43] | O43613 | HCRTR1 |
| T15795 | DI0309 | Obstructive sleep apnoea | [ICD-11: 7A41] | O14649 | KCNK3 |
| T36483 | DI0287 | Myocardial infarction | [ICD-11: BA41-BA43] | P25116 | F2R |
| T76396 | DI0241 | Lymphoma | [ICD-11: 2A80-2A86] | P53609 | PGGT1B |
| T47107 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | P05129 | PRKCG |
| T47107 | DI0248 | Mastocytosis | [ICD-11: 2A21] | P05129 | PRKCG |
| T08910 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P18507 | GABRG2 |
| T08910 | DI0256 | Mental/behavioural/neurodevelopmental disorder | [ICD-11: 6E20-6E8Z] | P18507 | GABRG2 |
| T08910 | DI0411 | Tonus and reflex abnormality | [ICD-11: MB47] | P18507 | GABRG2 |
| T82028 | DI0030 | Angina pectoris | [ICD-11: BA40] | P19634 | SLC9A1 |
| T88531 | DI0009 | Acute diabete complication | [ICD-11: 5A2Y] | O43194 | GPR39 |